ArticleJournal of cardiovascular development and disease2025
Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation.
Wissam Yared et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.